The global molybdenum 99 market size was valued at USD 4.14 billion in 2025 and is projected to grow from USD 4.37 billion in 2026 to USD 6.70 billion by 2034, registering a CAGR of 5.5% during the forecast period from 2026 to 2034. North America dominated the molybdenum 99 market with a market share of 39.5% in 2025.
Molybdenum-99 is a radioactive isotope primarily used to produce technetium-99m, the most widely utilized radioisotope in diagnostic nuclear medicine imaging. It plays a critical role in detecting and monitoring conditions such as cancer, cardiovascular diseases, and neurological disorders. Demand is driven by the increasing number of diagnostic imaging procedures, expanding nuclear medicine applications, and investments in reliable isotope production and healthcare infrastructure.
Download a Free Sample To learn more about this report,
Increasing Focus on Diversifying Global Molybdenum-99 Supply Sources
The molybdenum-99 market is increasingly focused on diversifying production sources to improve supply security and reduce dependence on a limited number of facilities. The concentration of global production among relatively few suppliers has encouraged governments, healthcare organizations, and isotope producers to strengthen supply resilience through geographically diversified production networks and alternative supply arrangements. This trend is supporting efforts to create a more secure and reliable global medical isotope supply chain.
In March 2025, medical isotope organizations continued supporting supply diversification initiatives aimed at improving the long-term security and resilience of essential radioisotope availability.
Growing Development of More Efficient and Sustainable Isotope Production Processes
The market is witnessing increased attention toward improving the efficiency and sustainability of molybdenum-99 production processes. Producers are exploring technologies and manufacturing approaches designed to optimize isotope yields, improve processing efficiency, reduce radioactive waste, and support more sustainable production practices. This technological development is contributing to the modernization of medical isotope manufacturing operations.
In July 2025, medical isotope producers continued advancing production and processing technologies focused on improving operational efficiency and supporting more sustainable isotope manufacturing practices.
Growing Demand for Nuclear Medicine Diagnostic Procedures
The growing use of diagnostic imaging for cardiovascular diseases, cancer, bone disorders, and other medical conditions is increasing demand for reliable technetium-99m availability. The expansion of nuclear medicine procedures therefore represents a fundamental driver for the molybdenum-99 market.
In April 2025, healthcare providers continued expanding the use of nuclear medicine imaging techniques to support the diagnosis and assessment of complex medical conditions.
High Cost and Complexity of Isotope Production Infrastructure
Producing molybdenum-99 requires specialized nuclear infrastructure, highly regulated facilities, advanced technical expertise, and complex handling processes. Establishing and maintaining these capabilities can involve substantial capital investment and operational costs. These financial and technical requirements can limit the entry of new producers into the market.
In June 2025, medical isotope producers continued managing significant infrastructure, regulatory, and operational requirements associated with establishing reliable isotope production capabilities.
Expansion of Nuclear Medicine Infrastructure in Emerging Healthcare Markets
Growing investment in healthcare infrastructure and nuclear medicine capabilities is creating opportunities for molybdenum-99 suppliers in emerging markets. The expansion of hospitals, diagnostic centers, and specialized imaging facilities can increase demand for medical radioisotopes. Improving access to nuclear medicine services therefore represents an important opportunity for market participants.
In September 2025, healthcare infrastructure development initiatives continued supporting the expansion of advanced diagnostic and nuclear medicine capabilities across emerging healthcare markets.
Managing the Short Half-Life and Complex Distribution Requirements
Molybdenum-99 has a relatively short half-life, making efficient production scheduling, transportation, and distribution essential. Delays in processing or logistics can reduce the usable activity available to healthcare providers and affect the availability of technetium-99m generators.
In November 2025, medical isotope suppliers continued focusing on production coordination and specialized logistics capabilities to support the timely delivery of short-lived radioisotopes to healthcare facilities.
Non-highly Enriched Uranium Segment Dominated the Market with 68.7% Share in 2025
The non-highly enriched uranium segment dominated the global molybdenum-99 market with a 68.7% share in 2025, driven by the growing adoption of low-enriched uranium targets for Molybdenum-99 production. Increasing regulatory support for non-proliferation initiatives, improved production technologies, and the ability to ensure a stable isotope supply continue to strengthen the segment's leading position.
The highly enriched uranium segment is witnessing steady demand in selected production facilities where existing infrastructure continues to support its use. However, ongoing investments in alternative production methods and the gradual transition toward low-enriched uranium are influencing the long-term evolution of this segment.
Growing focus on supply chain security, modernization of isotope production facilities, and advancements in reactor and accelerator-based technologies are expected to further support the expansion of non-highly enriched uranium production over the coming years.
Request Customizationto receive a tailored report.
Medical Segment Dominated the Market with 75.4% Share in 2025
The medical segment dominated the global molybdenum-99 market with a 75.4% share in 2025, supported by the widespread use of technetium-99m derived from Molybdenum-99 in nuclear medicine diagnostics. Increasing demand for diagnostic imaging procedures, early disease detection, and expanding healthcare infrastructure continue to reinforce the segment's leading position.
The scientific research segment is witnessing steady growth as universities, research laboratories, and nuclear science organizations continue to utilize radioisotopes for experimental studies, isotope production research, and the development of advanced imaging technologies.
Increasing investments in nuclear medicine research, radiopharmaceutical innovation, and isotope production capabilities are expected to create additional opportunities across both medical and scientific research applications.
SPECT Segment Dominated the Market with 56.2% Share in 2025
The SPECT segment dominated the global molybdenum-99 market with a 56.2% share in 2025, driven by its extensive use in diagnosing cardiovascular diseases, cancer, neurological disorders, and other chronic conditions. The high clinical value of SPECT imaging and the broad availability of technetium-99m radiopharmaceuticals continue to support strong market demand.
The gamma camera segment is witnessing steady growth as healthcare providers continue to upgrade diagnostic imaging systems to improve image quality, workflow efficiency, and patient outcomes. Increasing adoption of advanced nuclear imaging technologies is supporting the expansion of this segment.
Continuous improvements in imaging equipment, hybrid diagnostic systems, and radiopharmaceutical development are expected to further enhance the use of both SPECT and gamma camera technologies across healthcare facilities worldwide.
Hospitals and Diagnostic Centers Segment Dominated the Market with 73.1% Share in 2025
The hospitals and diagnostic centers segment dominated the global molybdenum-99 market with a 73.1% share in 2025, driven by the high volume of nuclear medicine procedures performed for disease diagnosis and patient monitoring. Growing demand for non-invasive imaging, expanding diagnostic capabilities, and increasing availability of nuclear medicine services continue to strengthen the segment's leading position.
The research institutes segment is witnessing steady growth as academic institutions and nuclear research organizations expand their work in isotope production, radiopharmaceutical development, and advanced medical imaging technologies. Increasing public and private investments in healthcare research continue to support the segment's expansion.
Ongoing collaboration between healthcare providers, research institutions, and isotope manufacturers is expected to accelerate innovation and improve the availability of Molybdenum-99, supporting long-term growth across both end-user segments.
Speak to an Analystto discuss market opportunities.
North America molybdenum-99 market accounted for 39.5% of the global market, reaching USD 1.64 billion in 2025, and is projected to grow at a CAGR of 7.62% during the forecast period. Rising demand for nuclear medicine procedures, increasing adoption of diagnostic imaging, and growing investments in radioisotope production continue to drive regional market growth. Ongoing modernization of nuclear medicine infrastructure is also supporting market expansion.
The U.S. market was valued at USD 1.39 billion in 2025, making it the largest contributor in North America. Growing demand for diagnostic imaging procedures, expanding nuclear medicine applications, and increasing investments in domestic radioisotope production continue to strengthen market growth.
Canada's market reached USD 0.25 billion in 2025. The country's strong expertise in radioisotope production, expanding healthcare infrastructure, and increasing demand for nuclear diagnostic procedures continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe molybdenum-99 market accounted for 27.8% of the global market, reaching USD 1.15 billion in 2025, and is expected to register a CAGR of 7.34% during the forecast period. Rising demand for advanced diagnostic imaging, expanding nuclear medicine facilities, and increasing investments in healthcare infrastructure are driving regional growth. Ongoing research in medical isotopes is further supporting market development.
Germany's market accounted for USD 0.33 billion in 2025. Strong healthcare infrastructure, growing use of nuclear imaging, and increasing investment in advanced diagnostic technologies continue to support market growth.
The UK market was valued at USD 0.24 billion in 2025. Rising demand for nuclear medicine procedures, expanding diagnostic services, and continuous healthcare investments continue to contribute to market expansion.
Asia Pacific molybdenum-99 market accounted for 22.4% of the global market, valued at USD 0.93 billion in 2025, and is projected to register a CAGR of 9.18% during the forecast period. Expanding healthcare infrastructure, increasing cancer diagnosis rates, growing adoption of nuclear medicine, and rising investments in medical imaging continue to accelerate regional market growth.
Japan's market generated USD 0.17 billion in 2025. Increasing use of advanced diagnostic imaging, expanding nuclear medicine applications, and strong healthcare spending continue to support market growth.
China's market accounted for USD 0.48 billion in 2025, representing the largest share within Asia Pacific. Expanding nuclear medicine facilities, increasing healthcare investments, and rising demand for radioisotopes used in diagnostic imaging continue to drive market expansion.
Latin America molybdenum-99 market accounted for 5.9% of the global market, reaching USD 0.24 billion in 2025, and is projected to grow at a CAGR of 7.21% during the forecast period. Improving healthcare infrastructure, increasing access to diagnostic imaging services, and rising awareness of early disease diagnosis continue to support regional market growth.
Brazil's market reached USD 0.12 billion in 2025. Growing investments in nuclear medicine, expanding diagnostic imaging centers, and increasing demand for advanced healthcare services continue to create growth opportunities across the country.
Middle East & Africa molybdenum-99 market accounted for 4.4% of the global market, totaling USD 0.18 billion in 2025, and is anticipated to grow at a CAGR of 6.88% during the forecast period. Rising healthcare investments, expanding diagnostic imaging capabilities, and increasing adoption of nuclear medicine technologies are supporting regional market growth.
The UAE market was valued at USD 0.06 billion in 2025. Government investments in advanced healthcare infrastructure, increasing availability of nuclear medicine services, and growing demand for early disease diagnosis continue to drive market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Head
Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.
His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.
Aluminum Market Size, Share, Growth, Analysis, Report, 2034
Sintered Steel Market Size, Share, Growth, Analysis, Report, 2034
Metallic Tiles Market Size, Share, Growth, 2034
Middle East and Africa Platinum Market Size, Share and Forecast to 2034
Asia-Pacific Platinum Market Size, Share & Trends Report by 2034
Europe Platinum Market Size, Share and Forecast to 2034
We are featured on:
sales@straitsresearch.com